Asahi Kasei Life Science | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

34,703 results for “Asahi Kasei Life Science”

Trials

View all 19721 →

The Asahi Intecc PTCA Chronic Total Occlusion Study

163 participants · First posted Mar 5, 2015

Clinical Study of Asahi ViE Dialyzer in Canada

17 participants · First posted Nov 17, 2014

Radifocus (Terumo) Versus Silverway (Asahi) to Deliver Catheters During Cardiac Catheterization

100 participants · First posted Feb 9, 2022

Drugs

View all 942 →

NMDA antagonists (Hokkaido University/Asahi Kasei)

Lantibiotic (Asahi Kasei Pharma)

PDE4B inhibitors (inflammation)(Asahi Kasei)

Organizations

View all 770 →

ASAHI KASEI PHARMA CORPORATION

Japan

INSTITUTE OF MEDICAL SCIENCE, ASAHI LIFE FOUNDATION, THE

Japan

ASAHI KASEI MEDICAL CO., LTD.

Japan

News

View all 13270 →

Asahi Kasei to Build Fourth Planova Virus Filter Plant in Japan with Government Support

Bionova Scientific Partners with Bionique Testing Laboratories for Mycoplasma Testing in Biologics Manufacturing

Viral Clearance Market Projected to Reach USD 4.8 Billion by 2036, Driven by Expanding Biologics Pipelines and Updated Regulatory Guidance

Page 1 of 3471